Sabril Powder, For Solution
Product Images NDC 67386-211

16 FDA label images from Lundbeck Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Sabril (NDC 67386-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Vigabatrin. (Sabril Powder For Oral Solution 1)

The Chemical Structure Of Vigabatrin. (Sabril Powder For Oral Solution 1)
Chemical structure of vigabatrin, the active ingredient in SABRIL. The structure shows a vinyl group, an amino group, and a carboxylic acid group consistent with the chemical composition of vigabatrin.*
FDA Label Image

Figure E (Sabril Powder For Oral Solution 10)

Figure E (Sabril Powder For Oral Solution 10)
An instructional diagram showing a close-up of a dosing syringe held by hand, highlighting the 10 mL line on the syringe barrel marked with an arrow and labeled '10 mL line.' This image is used to guide accurate measurement of oral liquid medication doses.*
FDA Label Image

Figure F (Sabril Powder For Oral Solution 11)

Figure F (Sabril Powder For Oral Solution 11)
An instructional illustration showing a hand holding a syringe with a capped needle or adapter, positioned above an empty glass container. This figure likely demonstrates a step in the preparation or administration process for SABRIL (vigabatrin) powder for solution oral dosage form.*
FDA Label Image

Figure G (Sabril Powder For Oral Solution 12)

Figure G (Sabril Powder For Oral Solution 12)
An instructional illustration labeled 'Figure G' showing a hand holding a spoon over an empty glass, likely demonstrating preparation or administration steps for a medication in powder form intended for oral solution.*
FDA Label Image

Figure H (Sabril Powder For Oral Solution 13)

Figure H (Sabril Powder For Oral Solution 13)
An instructional illustration labeled Figure H showing a hand holding a syringe inserted into a glass container, demonstrating the process of drawing liquid into the syringe.*
FDA Label Image

Figure I (Sabril Powder For Oral Solution 14)

Figure I (Sabril Powder For Oral Solution 14)
An instructional illustration showing a hand holding a syringe, likely demonstrating the preparation or measurement of a liquid dose, possibly related to the oral powder for solution form of SABRIL (vigabatrin). The syringe has visible volume markings.*
FDA Label Image

Figure J (Sabril Powder For Oral Solution 15)

Figure J (Sabril Powder For Oral Solution 15)
Illustration showing administration of oral medication to a young child using a syringe. A hand is holding the syringe at the child's mouth for oral delivery of the drug.*
FDA Label Image

Principal Display Panel Ndc 67386-211-65 Sabril® (vigabatrin) For Oral Solution 500 mg Dispense The Enclosed Medication Guide With Each Prescription. Rx Only 50 Packets (Sabril Powder For Oral Solution 16)

Principal Display Panel Ndc 67386-211-65 Sabril® (vigabatrin) For Oral Solution 500 mg Dispense The Enclosed Medication Guide With Each Prescription. Rx Only 50 Packets (Sabril Powder For Oral Solution 16)
Packaging label for SABRIL (vigabatrin) powder for oral solution, 500 mg per packet, in a box containing 50 packets. The label includes directions for mixing each packet with 10 mL of water and storage instructions. Manufactured by Patheon for Lundbeck Pharmaceuticals LLC. NDC 67386-211-65.*
FDA Label Image

Figure 1. Percent Reduction From Baseline In Seizure Frequency (Sabril Powder For Oral Solution 2)

Figure 1. Percent Reduction From Baseline In Seizure Frequency (Sabril Powder For Oral Solution 2)
A cumulative frequency plot showing the percentage reduction in seizure frequency versus percentage of patients. The graph compares placebo and three dosing regimens of vigabatrin (1g/day, 2g/day, and 3g/day). The vertical axis ranges from -100% to 100% change in seizure frequency, with 'No Change' marked at zero, and arrows indicating improvement and worsening. The horizontal axis shows the percent of patients from 0 to 100%, with different line styles representing each group.*
FDA Label Image

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Sabril Powder For Oral Solution 3)

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Sabril Powder For Oral Solution 3)
A cumulative distribution plot showing percentage reduction in seizure frequency versus percentage of patients for a treatment group receiving 3g/day vigabatrin (VGB) compared to placebo. The vertical axis represents percentage reduction in seizure frequency, indicating improvement or worsening, while the horizontal axis shows the proportion of patients.*
FDA Label Image

Supplies You Will Need To Mix 1 Dose Of Sabril (Sabril Powder For Oral Solution 4)

Supplies You Will Need To Mix 1 Dose Of Sabril (Sabril Powder For Oral Solution 4)
SABRIL 50 mg/mL powder for solution for oral use by Lundbeck Pharmaceuticals LLC. The image shows a clear container with a label indicating the product name and strength, alongside two syringes, a glass of water with a spoon, and a pair of scissors, suggesting preparation for oral administration.*
FDA Label Image

Oral Syringe Detail (Sabril Powder For Oral Solution 5)

Oral Syringe Detail (Sabril Powder For Oral Solution 5)
An illustration labeled 'Oral syringe detail' showing parts of an oral syringe including the tip, dosage indicators, barrel, plunger, and the bottom of the white plunger. The image visually explains these components of the oral syringe.*
FDA Label Image

Figure A (Sabril Powder For Oral Solution 6)

Figure A (Sabril Powder For Oral Solution 6)
Illustration showing a person pouring SABRIL (vigabatrin) oral powder for solution into a clear container. The image visually demonstrates the preparation step for the medication powder before oral administration.*
FDA Label Image

Figure B (Sabril Powder For Oral Solution 7)

Figure B (Sabril Powder For Oral Solution 7)
Figure B shows two clear glass containers on a plain surface, one filled with a clear liquid and the other empty. The image likely illustrates a step or comparison in the preparation or use of the oral powder solution, SABRIL (vigabatrin) 50 mg/mL from Lundbeck Pharmaceuticals LLC.*
FDA Label Image

Figure C (Sabril Powder For Oral Solution 8)

Figure C (Sabril Powder For Oral Solution 8)
An instructional illustration labeled Figure C shows a gloved hand holding a syringe that is being submerged into a clear glass of liquid, demonstrating a step likely related to dissolving or preparing the oral solution of SABRIL (vigabatrin) powder for solution.*
FDA Label Image

Figure D (Sabril Powder For Oral Solution 9)

Figure D (Sabril Powder For Oral Solution 9)
A black and white instructional illustration labeled Figure D showing a gloved hand holding a pre-filled oral dosing syringe with volume markings. The syringe is designed for accurate measurement and administration of oral liquid medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.